Clinical Trial
Published on 21 Nov 2023
Impact of everolimus plus calcineurin inhibitor on formation of non-HLA antibodies and graft outcomes in kidney transplant recipients: 12-month results from the ATHENA substudy
in Immunosuppression
- 2,160 views
- 6 citations





















